HealthTree Logo
search more_vert
close
person Sign In / Create Account

Dan Vogl, MD, MSCE

Myeloma Specialist

16 years treating Multiple Myeloma | 400 Multiple Myeloma patients treated annually

Clinical Expertise

  • Multiple Myeloma
  • Early phase clinical trials of new agents for myeloma therapy
  • Cellular Therapy and CAR T cells

About

Dan T. Vogl, MD, MSCE is Associate Professor of Medicine in the Division of Hematology and Oncology at the Abramson Cancer Center of the University of Pennsylvania in Philadelphia. Dr. Vogl sees patients with multiple myeloma, amyloidosis, and other plasma cell cancers. His clinical and translational research focuses on early phase clinical trials of novel therapies for relapsed and refractory multiple myeloma. Dr. Vogl also serves as Medical Director of the Abramson Cancer Center’s Clinical Research Unit, overseeing the work of over 140 research nurses, research coordinators, regulatory coordinators, and biospecimen coordinators, who together manage over 300 active cancer clinical trials. He is a member of Penn’s Myeloma Program, Amyloidosis Program, and Cellular Therapy and Transplant Program.

Location

Abramson Cancer Center: 3400 Civic Center Blvd, Philadelphia, PA 19104, USA

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
GSK
Regeneron
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube